Selinexor With Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia
Clinical trial NCT02573363 · COMPLETED
Trial details
- NCT number
- NCT02573363
- Sponsor
- University of Chicago
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-07
- Primary completion
- 2018-01-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.